Respondent demographics show that 6 % of Austrian respondents with T1DM were receiving basal-only insulin, however this formulation should only be used in patients with T2DM, and therefore we presume that most of these respondents incorrectly reported their diabetes type as T1DM. The gene discussed is INS; the disease is type 1 diabetes mellitus.